Quantinuum Inc. director Eric Branderiz increased his stake through a mix of grant and open-market buying. He received 5,833 shares of Class A Common Stock as a restricted stock unit (RSU) award on June 4, 2026, at a stated price of $0.00 per share. These RSUs vest in three equal annual installments beginning on June 5, 2027, each convertible into one share of Class A Common Stock.
On June 5, 2026, he made an open-market purchase of 8,334 shares at $60.00 per share. Following the purchase, his direct holdings reported in this filing rose to 14,167 shares of Class A Common Stock.
Quantinuum Inc. director Vimal Kapur reported an open-market purchase of 13,000 shares of Class A Common Stock. The transaction took place on 2026-06-05 at a price of $60.0000 per share. Following this purchase, Kapur directly holds 13,000 shares of Quantinuum common stock.
Quantinuum Inc. director Michal Stepniak reported an open-market purchase of Class A Common Stock. On June 5, he bought 13,333 shares at a price of $60.00 per share and now holds 13,333 shares directly following this transaction.
Quantinuum Inc. Chief Strategy Officer Kevin Scott Dehoff increased his direct stake in Class A Common Stock through both a grant and a market purchase. On June 3, 2026, he acquired 111,460 restricted shares in connection with a recapitalization transaction at a stated price of $0.00 per share. On June 5, 2026, he made an open-market purchase of an additional 15,000 shares at $60.00 per share. Following these transactions, Dehoff directly owns 126,460 Class A shares, aligning his interests more closely with shareholders ahead of the company’s initial public offering.
Quantinuum Inc. director Paul R. Daugherty reported two equity transactions in Class A Common Stock. He purchased 4,000 shares in an open-market transaction at $60.00 per share on June 5, 2026, bringing his directly held common shares to 9,833.
He also received a grant of 5,833 restricted stock units, each representing a contingent right to one share of Class A Common Stock. These RSUs vest in three equal annual installments beginning on June 5, 2027, adding a long-term, time-based equity component to his compensation.
Quantinuum Inc. director Kenneth D. Denman increased his stake through both a purchase and an equity award. He bought 14,000 shares of Class A Common Stock in an open-market transaction at $60.00 per share on June 5, 2026, bringing his directly held shares to 19,833.
On June 4, 2026, he also received a grant of 5,833 restricted stock units (RSUs), each representing one future share of Class A Common Stock. These RSUs vest in three equal annual installments beginning on June 5, 2027, adding a long-term, stock-based component to his compensation.
Quantinuum Inc. director Manish H. Bhatia reported new equity activity in Class A Common Stock. On June 5, 2026, he made an open-market purchase of 20,000 shares at $60.00 per share, increasing his direct holdings to 25,833 shares. On June 4, 2026, he also received a grant of 5,833 restricted stock units (RSUs), each representing one share, which will vest in three equal annual installments beginning on June 5, 2027.
Quantinuum Inc. director and President & CEO Rajeeb Hazra reported a series of equity compensation awards and related tax withholding in Class A Common Stock. He received 1,042,561 restricted stock units, each representing a right to one share of Class A Common Stock, which will vest in four equal annual installments beginning on June 5, 2027. He was also granted 122,791 stock options with a $60.00 exercise price, scheduled to vest in four equal annual installments beginning on June 5, 2027. In addition, he acquired 78,333 shares of restricted Class A Common Stock in connection with a recapitalization transaction. To satisfy tax liabilities upon vesting of restricted stock, 336,389 shares were withheld by the issuer at $60.00 per share, which the filing specifies was not a market sale. Following these transactions, Hazra directly holds 784,505 shares of Class A Common Stock.
Quantinuum Inc. is conducting an initial public offering of 28,000,000 shares of Class A common stock at an initial public offering price of $60.00 per share, representing aggregate gross proceeds of $1,680,000,000. The shares are approved for listing on Nasdaq under the symbol QNT.
After this offering (assuming no exercise of the underwriters' option), 32,862,895 shares of Class A common stock will be outstanding. Quantinuum Inc. intends to use net proceeds to purchase newly issued Common Units of Quantinuum Holdings at a per-unit price tied to the offering price, and Quantinuum Inc. will hold a 12.6% economic interest in Quantinuum Holdings immediately following the offering. The underwriters have a 30-day option to purchase an additional 4,200,000 shares.
Quantinuum Inc. director Eric Branderiz filed an initial Form 3 as a reporting person for the company. The filing identifies his role as a director and, in the data provided, shows no reported purchases, sales, derivative exercises, or other transactions in Quantinuum securities.